BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Treatment
147 results:

  • 1. Rare case of p16-positive oropharyngeal cancer metastasis to the orbit.
    Jeganathan C; Tan JL; Dhepnorrarat C
    BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38417943
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
    Wang WN; Liu XT; Liang YM
    Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
    [No Abstract]    [Full Text] [Related]  

  • 3. Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma.
    Lorenzo-Guerra SL; Codina-Martínez H; Suárez-Fernández L; Cabal VN; García-Marín R; Riobello C; Vivanco B; Blanco-Lorenzo V; Sánchez-Fernández P; López F; Llorente JL; Hermsen MA
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201285
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Combination of minimal residual disease on day 15 and copy number alterations results in BCR-ABL1-negative pediatric B-ALL: A powerful tool for prediction of induction failure.
    Baghdadi H; Soleimani M; Zavvar M; Bahoush G; Poopak B
    Cancer Genet; 2024 Apr; 282-283():27-34. PubMed ID: 38183785
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL.
    Bastian L; Beder T; Barz MJ; Bendig S; Bartsch L; Walter W; Wolgast N; Brändl B; Rohrandt C; Hansen BT; Hartmann AM; Iben K; Das Gupta D; Denker M; Zimmermann J; Wittig M; Chitadze G; Neumann M; Schneller F; Fiedler W; Steffen B; Stelljes M; Faul C; Schwartz S; Müller FJ; Cario G; Harder L; Haferlach C; Pfeifer H; Gökbuget N; Brüggemann M; Baldus CD
    Blood; 2024 Apr; 143(14):1391-1398. PubMed ID: 38153913
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Impact of the Identification of Nonhuman Genetic Signatures in the Diagnosis and Management of Carcinoma of Unknown Primary.
    Barquín García A; Palacios-Zambrano S; Lozano Alarcón F; Paumard-Hernández B; Quiralte Pulido M; Navarro P; Rodríguez L; Salas Villar I; García-Donas J
    J Natl Compr Canc Netw; 2023 Dec; 22(1D):e237079. PubMed ID: 38150820
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Surgical treatment of 186 sinonasal inverted papillomas and analysis of the immunohistochemical and molecular features associated with recurrences.
    Gras-Cabrerizo JR; Martel-Martin M; Casasayas-Plass M; Kolanczak K; Lopez-Vilaró L; Szafranska J; Massegur-Solench H; León-Vintró X
    Am J Otolaryngol; 2024; 45(2):104129. PubMed ID: 38070378
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comprehensive analysis of cancer of unknown primary and recommendation of a histological and immunohistochemical diagnostic strategy from China.
    Ren M; Cai X; Jia L; Bai Q; Zhu X; Hu X; Wang Q; Luo Z; Zhou X
    BMC Cancer; 2023 Dec; 23(1):1175. PubMed ID: 38041048
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Cutaneous metastasis from cervical cancer to the scalp and trunk: a case report and review of the literature.
    Dai Y; Zhang Y; Ke X; Liu Y; Zang C
    J Med Case Rep; 2023 Oct; 17(1):435. PubMed ID: 37853494
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The Landscape of Alterations from 1407 Ultra-Rare Sarcomas from the AACR GENIE Database: Clinical Implications.
    Denu RA; Moyers JT; Gouda MA; Conley AP; Lazar AJ; Subbiah V
    Clin Cancer Res; 2023 Nov; 29(22):4669-4678. PubMed ID: 37643131
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. KDM2B-Rearranged Soft Tissue Sarcomas Expand the Concept of BCOR-Associated Sarcoma.
    Motoi T; Hirata M; Kukita Y; Satomi K; Tamura H; Adachi S; Matsushita Y; Horiguchi SI; Hishima T; Ikegami M; Okuma T; Tao K; Arakawa A; Ogawa C; Matsuda K; Ichimura K; Nakamura H; Mori T; Yoshida A
    Mod Pathol; 2023 Nov; 36(11):100317. PubMed ID: 37634866
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Adult granulosa cell tumor of the testis with malignant tendency: A case report with genetic analysis using high-throughput sequencing.
    Deng L; Zeng J; Qiu JF; Yang LH; Ma J
    Medicine (Baltimore); 2023 Aug; 102(32):e34523. PubMed ID: 37565864
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy.
    Johnson WT; Ganesan N; Epstein-Peterson ZD; Moskowitz AJ; Stuver RN; Maccaro CR; Galasso N; Chang T; Khan N; Aypar U; Lewis NE; Zelenetz AD; Palomba ML; Matasar MJ; Noy A; Hamilton AM; Hamlin P; Caron PC; Straus DJ; Intlekofer AM; Lee Batlevi C; Kumar A; Owens CN; Sauter CS; Falchi L; Lue JK; Vardhana SA; Salles G; Dogan A; Schultz ND; Arcila ME; Horwitz SM
    Blood Adv; 2023 Sep; 7(17):5172-5186. PubMed ID: 37078708
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkers.
    Passeri T; Gutman T; Hamza A; Adle-Biassette H; Girard E; Beaurepere R; Tariq Z; Mariani O; Dahmani A; Bourneix C; Abbritti R; Driouch K; Bohec M; Servant N; Baulande S; Decaudin D; Guichard JP; Calugaru V; Feuvret L; Guinebretière JM; Champion L; Bièche I; Froelich S; Mammar H; Masliah-Planchon J
    J Neurosurg; 2023 Nov; 139(5):1270-1280. PubMed ID: 37029667
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinical Targeted Next-Generation Panel Sequencing Reveals
    Marinoff AE; Spurr LF; Fong C; Li YY; Forrest SJ; Ward A; Doan D; Corson L; Mauguen A; Pinto N; Maese L; Colace S; Macy ME; Kim A; Sabnis AJ; Applebaum MA; Laetsch TW; Glade-Bender J; Weiser DA; Anderson M; Crompton BD; Meyers P; Zehir A; MacConaill L; Lindeman N; Nowak JA; Ladanyi M; Church AJ; Cherniack AD; Shukla N; Janeway KA
    JCO Precis Oncol; 2023 Mar; 7():e2200334. PubMed ID: 36996377
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genomic features and its potential implication in bone oligometastatic NSCLC.
    Liao R; Yi G; Shen L; Zhang X; Xu Z; Peng Y; Yang Z
    BMC Pulm Med; 2023 Feb; 23(1):59. PubMed ID: 36755257
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and treatment Options.
    Tlemsani C; Larousserie F; De Percin S; Audard V; Hadjadj D; Chen J; Biau D; Anract P; Terris B; Goldwasser F; Pasmant E; Boudou-Rouquette P
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674874
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Carotenoid-Enriched Nanoemulsions and γ-Rays Synergistically Induce Cell Death in a Novel Radioresistant Osteosarcoma Cell Line.
    Russo M; Moccia S; Spagnuolo C; Tedesco I; Russo GL
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555605
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Small round cell sarcomas.
    Cidre-Aranaz F; Watson S; Amatruda JF; Nakamura T; Delattre O; de Alava E; Dirksen U; Grünewald TGP
    Nat Rev Dis Primers; 2022 Oct; 8(1):66. PubMed ID: 36202860
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. ZFTA::RELA fusion in a distinct liposarcoma morphologically overlapping with chondroid lipoma.
    Sumida S; Toki SI; Mori T; Satomi K; Takao S; Nobusawa S; Kakimoto T; Nakagawa S; Ryo E; Matsushita Y; Ichimura K; Nishisho T; Bando Y; Yoshida A
    Genes Chromosomes Cancer; 2023 Feb; 62(2):101-106. PubMed ID: 36201637
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.